Grants

“Cancer vaccines train the immune system to attack tumors without harming healthy tissue, but conventional approaches often fail to elicit rapid and robust enough responses against aggressive cancers. Funding from OCR will allow us to develop an innovative DNA cancer vaccine platform that generates quick and powerful immune defenses against tumor-specific antigen.”

Funding provided by Kimball Midwest/The McCurdy Family

“Immunotherapy has made significant progress in treating a subset of cancer patients. The generous support from OCR will enable us to develop new targets that can synergize with immunotherapy, helping to deliver better outcomes for patients who are not currently responding to treatment.”

“Despite recent advancements in treatments, approximately 20% of patients with B-cell acute lymphoblastic leukemia experience a return of the disease within two years of initial treatments. Only about half of these patients survive when leukemia returns. Funding from OCR will allow us to explore innovative approaches to treat leukemia and prevent the development of drug resistance. Our research aims to minimize the likelihood of disease recurrence and improve clinical outcomes.”

Funding provided by Kimball Midwest/The McCurdy Family

“Lung cancer is the leading cause of cancer-related deaths worldwide, thus novel anti-lung cancer therapeutic approaches are urgently needed. Our research will open novel therapeutic and research avenues for targeting lung cancer. Support from OCR serves as a foundation for this innovative project, aiming to identify pathways that can be targeted to treat lung cancer.”

“Receiving generous support from Ohio Cancer Research empowers our team to push the boundaries of cancer research, paving the way for innovative treatments and achieving an unprecedented level of understanding in cancer biology.”

“Our funded project with OCR will focus on utilizing IL-12 secreting myeloid cells and immune checkpoint blockade for the activation of cytotoxic cells to kill glioma cells before they undergo malignant progression. Having the support of OCR is critical for our ability to develop these novel innate immunotherapies.”

Funding provided by Kimball Midwest/The McCurdy Family

“Breast cancer is the most common cancer in females, affecting one in every eight women and accounting for the majority of cancer-related deaths in women worldwide. The generous funding from Ohio Cancer Research will pave the way for our research to receive federal funding and to improve breast cancer patient outcomes by developing novel prevention strategies.”

“Pancreatic cancer remains one of deadliest forms of cancer in the United States with a 5-year survival rate of less than 10 percent. The generous funding from Ohio Cancer Research will lay the groundwork for our research to receive federal funding and help to improve outcomes for pancreatic cancer patients.”